BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rodrigues S, Lopes S, Magro F, Cardoso H, Horta e Vale AM, Marques M, Mariz E, Bernardes M, Lopes J, Carneiro F, Macedo G. Autoimmune hepatitis and anti-tumor necrosis factor alpha therapy: A single center report of 8 cases. World J Gastroenterol 2015; 21(24): 7584-7588 [PMID: 26140007 DOI: 10.3748/wjg.v21.i24.7584]
URL: https://www.wjgnet.com/1007-9327/full/v21/i24/7584.htm
Number Citing Articles
1
Jinyu Zhang, Deepak Venkat. Frequent Offenders and Patterns of InjuryClinics in Liver Disease 2020; 24(1): 37 doi: 10.1016/j.cld.2019.09.002
2
Jun-Hua Fan, Geng-Feng Liu, Xiao-Dan Lv, Rui-Zhi Zeng, Ling-Ling Zhan, Xiao-Ping Lv. Pathogenesis of autoimmune hepatitisWorld Journal of Hepatology 2021; 13(8): 879-886 doi: 10.4254/wjh.v13.i8.879
3
Miren Garcia-Cortes, Mercedes Robles-Diaz, Camilla Stephens, Aida Ortega-Alonso, M. Isabel Lucena, Raúl J. Andrade. Drug induced liver injury: an updateArchives of Toxicology 2020; 94(10): 3381 doi: 10.1007/s00204-020-02885-1
4
Heba E. Elsayed, Hassan Y. Ebrahim, Mohamed S. Mady, Mohamed A. Khattab, Elsayed K. El-Sayed, Fatma A. Moharram. Ethnopharmacological impact of Melaleuca rugulosa (Link) Craven leaves extract on liver inflammationJournal of Ethnopharmacology 2022; 292: 115215 doi: 10.1016/j.jep.2022.115215
5
Briette Karanfilian, Noah Mahpour, Avik Sarkar. Infliximab Drug-Induced Autoimmune Hepatitis in a Patient With Crohn's IleocolitisAmerican Journal of Therapeutics 2022; 29(6): e741 doi: 10.1097/MJT.0000000000001230
6
Kyley Leroy, Emma E. Furth, Frederick Nunes. Etanercept-Induced Autoimmune HepatitisAmerican Journal of Gastroenterology 2016; 111: S934 doi: 10.14309/00000434-201610001-01956
7
Galina V. Volynets, A. I. Khavkin, T. A. Skvortsova, V. V. Matkash, A. V. Nikitin. SCLEROSING CHOLANGITIS IN CHILDREN AND ADOLESCENTS: CURRENT STATE OF THE PROBLEMRussian Pediatric Journal 2019; 21(5): 312 doi: 10.18821/1560-9561-2018-21-5-312-318
8
Helgi Kristinn Björnsson, Bjorn Gudbjornsson, Einar Stefan Björnsson. Infliximab-induced liver injury: Clinical phenotypes, autoimmunity and the role of corticosteroid treatmentJournal of Hepatology 2022; 76(1): 86 doi: 10.1016/j.jhep.2021.08.024
9
KASL clinical practice guidelines for management of autoimmune hepatitis 2022Clinical and Molecular Hepatology 2023; 29(3): 542 doi: 10.3350/cmh.2023.0087
10
Harshad Devarbhavi, Guruprasad Aithal, Sombat Treeprasertsuk, Hajime Takikawa, Yimin Mao, Saggere M. Shasthry, Saeed Hamid, Soek Siam Tan, Cyriac Abby Philips, Jacob George, Wasim Jafri, Shiv K. Sarin. Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelinesHepatology International 2021; 15(2): 258 doi: 10.1007/s12072-021-10144-3
11
Diego Vergani, Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani. A reasoned approach to the treatment of autoimmune hepatitisDigestive and Liver Disease 2021; 53(11): 1381 doi: 10.1016/j.dld.2021.05.033
12
David E. Kleiner. Recent Advances in the Histopathology of Drug-Induced Liver InjurySurgical Pathology Clinics 2018; 11(2): 297 doi: 10.1016/j.path.2018.02.009
13
Philip Sarges, Joshua M Steinberg, James H Lewis. Drug-Induced Liver Injury: Highlights from a Review of the 2015 LiteratureDrug Safety 2016; 39(9): 801 doi: 10.1007/s40264-016-0427-8
14
Beverley Kok, Erica L. W. Lester, William M. Lee, A. James Hanje, R. Todd Stravitz, Safwat Girgis, Vaishali Patel, Joshua R. Peck, Christopher Esber, Constantine J. Karvellas. Acute Liver Failure from Tumor Necrosis Factor-α Antagonists: Report of Four Cases and Literature ReviewDigestive Diseases and Sciences 2018; 63(6): 1654 doi: 10.1007/s10620-018-5023-6
15
Sara Harsini, Nima Rezaei. Clinical Immunology2023; : 123 doi: 10.1016/B978-0-12-818006-8.00001-3
16
Parth Shah, Vinay Sundaram, Einar Björnsson. Biologic and Checkpoint Inhibitor‐Induced Liver Injury: A Systematic Literature ReviewHepatology Communications 2020; 4(2): 172 doi: 10.1002/hep4.1465
17
Diego Vergani, Ian R. Mackay, Giorgina Mieli-Vergani. The Autoimmune Diseases2020; : 1117 doi: 10.1016/B978-0-12-812102-3.00057-9
18
Urs Christen, Edith Hintermann. Animal Models for Autoimmune Hepatitis: Are Current Models Good Enough?Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.898615
19
C. Iking-Konert, W.-J. Mayet, S. Kuchen, J. Jenewein, S. Büchi, H. Zeidler, B. Michel. Differenzialdiagnose rheumatischer Erkrankungen2019; : 363 doi: 10.1007/978-3-662-56575-9_10
20
José Miranda-Bautista, Luis Menchén. Adalimumab-induced autoimmune hepatitis in a patient with Crohn's diseaseGastroenterología y Hepatología (English Edition) 2019; 42(5): 306 doi: 10.1016/j.gastre.2018.06.015
21
Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani. Contemporary issues and future directions in autoimmune hepatitisExpert Review of Gastroenterology & Hepatology 2016; 10(10): 1163 doi: 10.1080/17474124.2016.1193004
22
Carlo Selmi, Elena Generali, Merrill Eric Gershwin. Rheumatic Manifestations in Autoimmune Liver DiseaseRheumatic Disease Clinics of North America 2018; 44(1): 65 doi: 10.1016/j.rdc.2017.09.008
23
M. Nedim Ince, David E. Elliott. Effective Use of the Laboratory in the Management of Patients with Inflammatory Bowel DiseasesGastroenterology Clinics of North America 2019; 48(2): 237 doi: 10.1016/j.gtc.2019.02.006
24
Giovanni Vitale, Stefano Gitto, Claudia Campani, Laura Turco, Anna Baldan, Fabio Marra, Maria Cristina Morelli. Biological therapies in patients with liver disease: are they really lifesavers?Expert Opinion on Biological Therapy 2022; 22(4): 473 doi: 10.1080/14712598.2022.2013799
25
Aliya Gulamhusein, Patrick McKiernan. Autoimmune Liver Disease2020; : 103 doi: 10.1002/9781119532637.ch6
26
Atsushi Takahashi, Hiromasa Ohira. Gastrointestinal and Hepatic Manifestations of Rheumatic Diseases2019; : 1 doi: 10.1007/978-981-13-6524-9_1
27
Giorgina Mieli‐Vergani, Diego Vergani, Ulrich Baumann, Piotr Czubkowski, Dominique Debray, Antal Dezsofi, Björn Fischler, Girish Gupte, Loreto Hierro, Giuseppe Indolfi, Jörg Jahnel, Françoise Smets, Henkjan J. Verkade, Nedim Hadžić. Diagnosis and Management of Pediatric Autoimmune Liver DiseaseJournal of Pediatric Gastroenterology and Nutrition 2018; 66(2): 345 doi: 10.1097/MPG.0000000000001801
28
Einar S. Björnsson. Autoimmune Hepatitis-Induced by Drugs: a Challenging DiagnosisCurrent Hepatology Reports 2017; 16(4): 265 doi: 10.1007/s11901-017-0365-7
29
Franziska Muscate, Anna Woestemeier, Nicola Gagliani. Functional heterogeneity of CD4+ T cells in liver inflammationSeminars in Immunopathology 2021; 43(4): 549 doi: 10.1007/s00281-021-00881-w
30
José Fabiano Costa Justus, Antonio Carlos Ligocki Campos, Ana Lucia C. Figueroa, Ramon Gomis, Marco Aurélio Santo, Giovani Marino Fávero, Fábio Quirillo Milléo, Elaine Vieira. Early Effect of Bariatric Surgery on the Circadian Rhythms of Adipokines in Morbidly Obese WomenMetabolic Syndrome and Related Disorders 2016; 14(1): 16 doi: 10.1089/met.2015.0051
31
Benjamin Click, Miguel Regueiro. A Practical Guide to the Safety and Monitoring of New IBD TherapiesInflammatory Bowel Diseases 2019; 25(5): 831 doi: 10.1093/ibd/izy313
32
Benjamin Click, Miguel Regueiro. Managing Risks with BiologicsCurrent Gastroenterology Reports 2019; 21(1) doi: 10.1007/s11894-019-0669-6
33
Joshua Korzenik, Michael Due Larsen, Jan Nielsen, Jens Kjeldsen, Bente Mertz Nørgård. Increased risk of developing Crohn’s disease or ulcerative colitis in 17 018 patients while under treatment with anti‐TNFα agents, particularly etanercept, for autoimmune diseases other than inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics 2019; 50(3): 289 doi: 10.1111/apt.15370
34
Cara L. Mack, David Adams, David N. Assis, Nanda Kerkar, Michael P. Manns, Marlyn J. Mayo, John M. Vierling, Mouaz Alsawas, Mohammad H. Murad, Albert J. Czaja. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesHepatology 2020; 72(2): 671 doi: 10.1002/hep.31065
35
Xianli Yuan, Yan Li, Xiuhe Pan, Xiao Peng, Gaihuan Song, Wenwen Jiang, Qiaoyan Gao, Mingcai Li. IL-38 alleviates concanavalin A-induced liver injury in miceInternational Immunopharmacology 2016; 40: 452 doi: 10.1016/j.intimp.2016.09.023
36
Su Jin Choi, Ji Seon Oh, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Yong-Gil Kim. Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort studyThe Korean Journal of Internal Medicine 2020; 35(3): 723 doi: 10.3904/kjim.2018.407
37
Herbert Tilg, Timon E. Adolph, Frank Tacke. Therapeutic modulation of the liver immune microenvironmentHepatology 2023; 78(5): 1581 doi: 10.1097/HEP.0000000000000386
38
Einar S. Björnsson, Vesna Vucic, Guido Stirnimann, Mercedes Robles-Díaz. Role of Corticosteroids in Drug-Induced Liver Injury. A Systematic ReviewFrontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.820724
39
Fernanda Monge-Urrea, Ericka Montijo-Barrios. Drug-induced Liver Injury in PediatricsJournal of Pediatric Gastroenterology & Nutrition 2022; 75(4): 391 doi: 10.1097/MPG.0000000000003535
40
Ora Shovman, Shalev Tamar, Howard Amital, Abdulla Watad, Yehuda Shoenfeld. Diverse patterns of anti-TNF-α-induced lupus: case series and review of the literatureClinical Rheumatology 2018; 37(2): 563 doi: 10.1007/s10067-017-3884-2
41
Bastian Engel, Alena Laschtowitz, Maciej K. Janik, Norman Junge, Ulrich Baumann, Piotr Milkiewicz, Richard Taubert, Marcial Sebode. Genetic aspects of adult and pediatric autoimmune hepatitis: A concise reviewEuropean Journal of Medical Genetics 2021; 64(6): 104214 doi: 10.1016/j.ejmg.2021.104214
42
G. V. Volynets, A. I. Khavkin, T. A. Skvortsova, V. V. Matkash. Autoimmune Hepatitis in Children: The Current State of the ProblemRussian Journal of Gastroenterology, Hepatology, Coloproctology 2018; 28(5): 18 doi: 10.22416/1382-4376-2018-28-5-18-34
43
Marilena Durazzo, Giulia Lupi, Michela Scandella, Arianna Ferro, Gabriella Gruden. Autoimmune hepatitis treatment in the elderly: A systematic reviewWorld Journal of Gastroenterology 2019; 25(22): 2809-2818 doi: 10.3748/wjg.v25.i22.2809
44
Paulina Núñez F, Fabiola Castro, Gabriel Mezzano, Rodrigo Quera, Diego Diaz, Lorena Castro. Hepatobiliary manifestations in inflammatory bowel disease: A practical approachWorld Journal of Hepatology 2022; 14(2): 319-337 doi: 10.4254/wjh.v14.i2.319
45
Liping Guo, Lu Zhou, Na Zhang, Baoru Deng, Bangmao Wang. Extrahepatic Autoimmune Diseases in Patients with Autoimmune Liver Diseases: A Phenomenon Neglected by GastroenterologistsGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/2376231
46
João Santos-Antunes, Amadeu Corte-Real Nunes, Susana Lopes, Guilherme Macedo. The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF TreatmentInflammatory Bowel Diseases 2016; 22(5): 1101 doi: 10.1097/MIB.0000000000000697
47
Albert J. Czaja. Evolving paradigm of treatment for autoimmune hepatitisExpert Review of Clinical Immunology 2017; 13(8): 781 doi: 10.1080/1744666X.2017.1319764
48
Muhammed Mustafa Alikhan, Emad Mansoor, Sagarika Satyavada, Katarina Greer, Wei Xin, Stanley Cohen, Gregory Cooper, Jeffry Katz. Infliximab-Induced Acute Liver Failure in a Patient With Crohn's Disease Requiring Orthotopic Liver TransplantationACG Case Reports Journal 2021; 8(5): e00586 doi: 10.14309/crj.0000000000000586
49
José Miranda-Bautista, Luis Menchén. Adalimumab-induced autoimmune hepatitis in a patient with Crohn's diseaseGastroenterología y Hepatología 2019; 42(5): 306 doi: 10.1016/j.gastrohep.2018.06.006
50
Lucy Shamberg, Haleh Vaziri. Hepatotoxicity of Inflammatory Bowel Disease MedicationsJournal of Clinical Gastroenterology 2018; 52(8): 674 doi: 10.1097/MCG.0000000000001084
51
Nwe Ni Than, Hannah C. Jeffery, Ye H. Oo. Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell TherapyCanadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/7181685
52
Sara Massironi, Lorena Pirola, Giacomo Mulinacci, Antonio Ciaccio, Chiara Viganò, Andrea Palermo, Alessandra Zilli, Pietro Invernizzi, Silvio Danese. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and TricksInflammatory Bowel Diseases 2023; 29(9): 1477 doi: 10.1093/ibd/izac189
53
Frederick Wong, Bashaar Al Ibrahim, Joanna Walsh, Karim Qumosani. Infliximab‐induced autoimmune hepatitis requiring liver transplantationClinical Case Reports 2019; 7(11): 2135 doi: 10.1002/ccr3.2456
54
Sabine Weber, Alexander L. Gerbes. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune HepatitisDigestion 2023; 104(3): 243 doi: 10.1159/000528329
55
Paulina Núñez F, Rodrigo Quera, Constanza Bay, Fabiola Castro, Gabriel Mezzano. Drug-Induced Liver Injury Used in the Treatment of Inflammatory Bowel DiseaseJournal of Crohn's and Colitis 2022; 16(7): 1168 doi: 10.1093/ecco-jcc/jjac013
56
Aida Ortega-Alonso, Camilla Stephens, M. Lucena, Raúl Andrade. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver InjuryInternational Journal of Molecular Sciences 2016; 17(5): 714 doi: 10.3390/ijms17050714
57
Iliana Doycheva, Kymberly D. Watt, Aliya F. Gulamhusein. Autoimmune hepatitis: Current and future therapeutic optionsLiver International 2019; 39(6): 1002 doi: 10.1111/liv.14062
58
Albert J. Czaja. Advancing Biologic Therapy for Refractory Autoimmune HepatitisDigestive Diseases and Sciences 2022; 67(11): 4979 doi: 10.1007/s10620-021-07378-4
59
Fernando Bessone, Einar S. Björnsson. Drug-Induced Liver Injury due to Biologics and Immune Check Point InhibitorsMedical Clinics of North America 2023; 107(3): 623 doi: 10.1016/j.mcna.2022.12.008
60
Loris Lopetuso, Giammarco Mocci, Manuela Marzo, Francesca D’Aversa, Gian Rapaccini, Luisa Guidi, Alessandro Armuzzi, Antonio Gasbarrini, Alfredo Papa. Harmful Effects and Potential Benefits of Anti-Tumor Necrosis Factor (TNF)-α on the LiverInternational Journal of Molecular Sciences 2018; 19(8): 2199 doi: 10.3390/ijms19082199
61
Leon D. Averbukh, George Y. Wu. Role of Biologics in the Development of Autoimmune Hepatitis: A ReviewJournal of Clinical and Translational Hepatology 2018; 6(4): 1 doi: 10.14218/JCTH.2018.00039
62
Ariane G. S. Araujo, Helena H. L. Borba, Fernanda S. Tonin, Luana Lenzi, Rafael Venson, Roberto Pontarolo, Astrid Wiens. Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS)BioDrugs 2018; 32(4): 377 doi: 10.1007/s40259-018-0285-2
63
Elisabeth Sucher, Robert Sucher, Tanja Gradistanac, Gerald Brandacher, Stefan Schneeberger, Thomas Berg. Autoimmune Hepatitis—Immunologically Triggered Liver Pathogenesis—Diagnostic and Therapeutic StrategiesJournal of Immunology Research 2019; 2019: 1 doi: 10.1155/2019/9437043
64
Christopher Chang, Atsushi Tanaka, Christopher Bowlus, M. Eric Gershwin. The use of biologics in the treatment of autoimmune liver diseaseExpert Opinion on Investigational Drugs 2020; 29(4): 385 doi: 10.1080/13543784.2020.1733527
65
Giorgina Mieli-Vergani, Diego Vergani. Pediatric Hepatology and Liver Transplantation2019; : 175 doi: 10.1007/978-3-319-96400-3_10
66
Omar Yesid Martínez‐Casas, Gabriel Sebastián Díaz‐Ramírez, Juan Ignacio Marín‐Zuluaga, Octavio Muñoz‐Maya, Oscar Santos, Jorge Hernando Donado‐Gómez, Juan Carlos Restrepo‐Gutiérrez. Differential characteristics in drug‐induced autoimmune hepatitisJGH Open 2018; 2(3): 97 doi: 10.1002/jgh3.12054
67
Benedetta Terziroli Beretta-Piccoli, Giorgina Mieli-Vergani, Diego Vergani. Autoimmune hepatitis: Standard treatment and systematic review of alternative treatmentsWorld Journal of Gastroenterology 2017; 23(33): 6030-6048 doi: 10.3748/wjg.v23.i33.6030
68
Uni Wong, Raymond K. Cross. Treatment of Inflammatory Bowel Disease with Biologics2018; : 231 doi: 10.1007/978-3-319-60276-9_14
69
Raúl J. Andrade, Guruprasad P. Aithal, Ynto S. de Boer, Rodrigo Liberal, Alexander Gerbes, Arie Regev, Benedetta Terziroli Beretta-Piccoli, Christoph Schramm, David E. Kleiner, Eleonora De Martin, Gerd A. Kullak-Ublick, Guido Stirnimann, Harshad Devarbhavi, John M. Vierling, Michael P. Manns, Marcial Sebode, Maria Carlota Londoño, Mark Avigan, Mercedes Robles-Diaz, Miren García-Cortes, Edmond Atallah, Michael Heneghan, Naga Chalasani, Palak J. Trivedi, Paul H. Hayashi, Richard Taubert, Robert J. Fontana, Sabine Weber, Ye Htun Oo, Yoh Zen, Anna Licata, M Isabel Lucena, Giorgina Mieli-Vergani, Diego Vergani, Einar S. Björnsson. Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): An expert opinion meeting reportJournal of Hepatology 2023; 79(3): 853 doi: 10.1016/j.jhep.2023.04.033
70
Irina Adao, Arielle Klepper, Michele Tana. AIH Therapy: Beyond First-LineCurrent Hepatology Reports 2024;  doi: 10.1007/s11901-024-00657-4
71
Claudia S. Bovensiepen, Miriam Schakat, Marcial Sebode, Roman Zenouzi, Johannes Hartl, Moritz Peiseler, Jun Li, Lara Henze, Anna Woestemeier, Christoph Schramm, Ansgar W. Lohse, Johannes Herkel, Christina Weiler-Normann. TNF-Producing Th1 Cells Are Selectively Expanded in Liver Infiltrates of Patients with Autoimmune HepatitisThe Journal of Immunology 2019; 203(12): 3148 doi: 10.4049/jimmunol.1900124
72
Ludovico De Stefano, Francesca Bobbio Pallavicini, Eleonora Mauric, Veronica Piccin, Enrico Maria Vismara, Carlomaurizio Montecucco, Serena Bugatti. Tumor necrosis factor-α inhibitor-related autoimmune disordersAutoimmunity Reviews 2023; 22(7): 103332 doi: 10.1016/j.autrev.2023.103332
73
Amanda Ricciuto, Binita M. Kamath, Thomas D. Walters, Karen Frost, Nicholas Carman, Peter C. Church, Simon C. Ling, Anne M. Griffiths. New Onset Autoimmune Hepatitis during Anti-Tumor Necrosis Factor-Alpha Treatment in ChildrenThe Journal of Pediatrics 2018; 194: 128 doi: 10.1016/j.jpeds.2017.10.071
74
Joshua B. French, Maurizio Bonacini, Marwan Ghabril, David Foureau, Herbert L. Bonkovsky. Hepatotoxicity Associated with the Use of Anti-TNF-α AgentsDrug Safety 2016; 39(3): 199 doi: 10.1007/s40264-015-0366-9
75
Naotaka Serizawa, Toshihiko Hoashi, Hidehisa Saeki, Naoko Kanda. A Case of Autoimmune Hepatitis during Brodalumab Treatment for PsoriasisJournal of Nippon Medical School 2020; 87(6): 359 doi: 10.1272/jnms.JNMS.2020_87-607
76
Michele S. Barnhill, Joshua M. Steinberg, Joseph J. Jennings, James H. Lewis. Hepatotoxicty of Agents Used in the Management of Inflammatory Bowel Disease: a 2020 UpdateCurrent Gastroenterology Reports 2020; 22(9) doi: 10.1007/s11894-020-00781-3
77
Tomislav Ledenko, Iva Sorić Hosman, Marijana Ćorić, Alenka Gagro. Case Report: Simultaneously Developed Amyopathic Dermatomyositis and Autoimmune Sclerosing Cholangitis – a Coincidence or a Shared Immunopathogenesis?Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.825799
78
Adalimumab/infliximabReactions Weekly 2015; 1563(1): 18 doi: 10.1007/s40278-015-3947-6
79
Shamir Cassim, Marc Bilodeau, Catherine Vincent, Pascal Lapierre. Novel Immunotherapies for Autoimmune HepatitisFrontiers in Pediatrics 2017; 5 doi: 10.3389/fped.2017.00008